Cargando…

Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients

INTRODUCTION: The purpose of this study was to evaluate the clinical relevance of high values of central venous-to-arterial carbon dioxide difference (PCO(2) gap) in high-risk surgical patients admitted to a postoperative ICU. We hypothesized that PCO(2) gap could serve as a useful tool to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Robin, Emmanuel, Futier, Emmanuel, Pires, Oscar, Fleyfel, Maher, Tavernier, Benoit, Lebuffe, Gilles, Vallet, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486687/
https://www.ncbi.nlm.nih.gov/pubmed/25967737
http://dx.doi.org/10.1186/s13054-015-0917-6
_version_ 1782378911497191424
author Robin, Emmanuel
Futier, Emmanuel
Pires, Oscar
Fleyfel, Maher
Tavernier, Benoit
Lebuffe, Gilles
Vallet, Benoit
author_facet Robin, Emmanuel
Futier, Emmanuel
Pires, Oscar
Fleyfel, Maher
Tavernier, Benoit
Lebuffe, Gilles
Vallet, Benoit
author_sort Robin, Emmanuel
collection PubMed
description INTRODUCTION: The purpose of this study was to evaluate the clinical relevance of high values of central venous-to-arterial carbon dioxide difference (PCO(2) gap) in high-risk surgical patients admitted to a postoperative ICU. We hypothesized that PCO(2) gap could serve as a useful tool to identify patients still requiring hemodynamic optimization at ICU admission. METHODS: One hundred and fifteen patients were included in this prospective single-center observational study during a 1-year period. High-risk surgical inclusion criteria were adapted from Schoemaker and colleagues. Demographic and biological data, PCO(2) gap, central venous oxygen saturation, lactate level and postoperative complications were recorded for all patients at ICU admission, and 6 hours and 12 hours after admission. RESULTS: A total of 78 (68%) patients developed postoperative complications, of whom 54 (47%) developed organ failure. From admission to 12 hours after admission, there was a significant difference in mean PCO(2) gap (8.7 ± 2.8 mmHg versus 5.1 ± 2.6 mmHg; P = 0.001) and median lactate values (1.54 (1.1-3.2) mmol/l versus 1.06 (0.8-1.8) mmol/l; P = 0.003) between patients who developed postoperative complications and those who did not. These differences were maximal at admission to the ICU. At ICU admission, the area under the receiver operating characteristic curve for occurrence of postoperative complications was 0.86 for the PCO(2) gap compared to Sequential Organ Failure Assessment score (0.82), Simplified Acute Physiology Score II score (0.67), and lactate level (0.67). The threshold value for PCO(2) gap was 5.8 mmHg. Multivariate analysis showed that only a high PCO(2) gap and a high Sequential Organ Failure Assessment score were independently associated with the occurrence of postoperative complications. A high PCO(2) gap (≥6 mmHg) was associated with more organ failure, an increase in duration of mechanical ventilation and length of hospital stay. CONCLUSION: A high PCO(2) gap at admission in the postoperative ICU was significantly associated with increased postoperative complications in high-risk surgical patients. If the increase in PCO(2) gap is secondary to tissue hypoperfusion then the PCO(2) gap might be a useful tool complementary to central venous oxygen saturation as a therapeutic target.
format Online
Article
Text
id pubmed-4486687
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44866872015-07-02 Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients Robin, Emmanuel Futier, Emmanuel Pires, Oscar Fleyfel, Maher Tavernier, Benoit Lebuffe, Gilles Vallet, Benoit Crit Care Research INTRODUCTION: The purpose of this study was to evaluate the clinical relevance of high values of central venous-to-arterial carbon dioxide difference (PCO(2) gap) in high-risk surgical patients admitted to a postoperative ICU. We hypothesized that PCO(2) gap could serve as a useful tool to identify patients still requiring hemodynamic optimization at ICU admission. METHODS: One hundred and fifteen patients were included in this prospective single-center observational study during a 1-year period. High-risk surgical inclusion criteria were adapted from Schoemaker and colleagues. Demographic and biological data, PCO(2) gap, central venous oxygen saturation, lactate level and postoperative complications were recorded for all patients at ICU admission, and 6 hours and 12 hours after admission. RESULTS: A total of 78 (68%) patients developed postoperative complications, of whom 54 (47%) developed organ failure. From admission to 12 hours after admission, there was a significant difference in mean PCO(2) gap (8.7 ± 2.8 mmHg versus 5.1 ± 2.6 mmHg; P = 0.001) and median lactate values (1.54 (1.1-3.2) mmol/l versus 1.06 (0.8-1.8) mmol/l; P = 0.003) between patients who developed postoperative complications and those who did not. These differences were maximal at admission to the ICU. At ICU admission, the area under the receiver operating characteristic curve for occurrence of postoperative complications was 0.86 for the PCO(2) gap compared to Sequential Organ Failure Assessment score (0.82), Simplified Acute Physiology Score II score (0.67), and lactate level (0.67). The threshold value for PCO(2) gap was 5.8 mmHg. Multivariate analysis showed that only a high PCO(2) gap and a high Sequential Organ Failure Assessment score were independently associated with the occurrence of postoperative complications. A high PCO(2) gap (≥6 mmHg) was associated with more organ failure, an increase in duration of mechanical ventilation and length of hospital stay. CONCLUSION: A high PCO(2) gap at admission in the postoperative ICU was significantly associated with increased postoperative complications in high-risk surgical patients. If the increase in PCO(2) gap is secondary to tissue hypoperfusion then the PCO(2) gap might be a useful tool complementary to central venous oxygen saturation as a therapeutic target. BioMed Central 2015-05-13 2015 /pmc/articles/PMC4486687/ /pubmed/25967737 http://dx.doi.org/10.1186/s13054-015-0917-6 Text en © Robin et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Robin, Emmanuel
Futier, Emmanuel
Pires, Oscar
Fleyfel, Maher
Tavernier, Benoit
Lebuffe, Gilles
Vallet, Benoit
Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients
title Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients
title_full Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients
title_fullStr Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients
title_full_unstemmed Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients
title_short Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients
title_sort central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486687/
https://www.ncbi.nlm.nih.gov/pubmed/25967737
http://dx.doi.org/10.1186/s13054-015-0917-6
work_keys_str_mv AT robinemmanuel centralvenoustoarterialcarbondioxidedifferenceasaprognostictoolinhighrisksurgicalpatients
AT futieremmanuel centralvenoustoarterialcarbondioxidedifferenceasaprognostictoolinhighrisksurgicalpatients
AT piresoscar centralvenoustoarterialcarbondioxidedifferenceasaprognostictoolinhighrisksurgicalpatients
AT fleyfelmaher centralvenoustoarterialcarbondioxidedifferenceasaprognostictoolinhighrisksurgicalpatients
AT tavernierbenoit centralvenoustoarterialcarbondioxidedifferenceasaprognostictoolinhighrisksurgicalpatients
AT lebuffegilles centralvenoustoarterialcarbondioxidedifferenceasaprognostictoolinhighrisksurgicalpatients
AT valletbenoit centralvenoustoarterialcarbondioxidedifferenceasaprognostictoolinhighrisksurgicalpatients